We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Pilot Study Comparing the Use of Low-target Versus Conventional Target Advagraf (Astellas)

This study is currently recruiting participants.
Verified June 2016 by University of British Columbia
Sponsor:
ClinicalTrials.gov Identifier:
NCT01265537
First Posted: December 23, 2010
Last Update Posted: June 29, 2016
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
Collaborator:
Astellas Pharma Canada, Inc.
Information provided by (Responsible Party):
University of British Columbia
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2017
  Estimated Primary Completion Date: December 2017 (Final data collection date for primary outcome measure)